Literature DB >> 15661383

Correlates of HIV vaccine trial participation: an Indian perspective.

Seema Sahay1, Sanjay Mehendale, Suvarna Sane, Radhika Brahme, Amishah Brown, Karen Charron, Chris Beyrer, Robert Bollinger, Ramesh Paranjape.   

Abstract

Successful conduct of HIV vaccine trials in a population of great cultural diversity like India could be a challenge. Concerns, knowledge gaps and willingness to participate in future HIV vaccine trials were studied among 349 patients attending three sexually transmitted infections clinics and one reproductive tract infections clinic. Overall willingness to volunteer for HIV vaccine trials was 48%. Women and men at risk of HIV infection were willing to participate in the HIV vaccine trials. Factors associated with increased willingness to participate in these trials were awareness of current HIV vaccine efforts, realization of importance of vaccine for self, concern about adverse events and altruism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661383     DOI: 10.1016/j.vaccine.2004.09.032

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

Review 1.  Experiences in recruiting volunteers through community based initiatives in phase-1 vaccine trials in India.

Authors:  Seema Sahay; Makesh Kumar; Aylur K Srikrishnan; Vadakkuppatu Ramanathan; Sanjay Mehendale
Journal:  Hum Vaccin Immunother       Date:  2013-10-18       Impact factor: 3.452

2.  Barriers to adolescents' participation in HIV biomedical prevention research.

Authors:  Ralph J DiClemente; Monica S Ruiz; Jessica McDermott Sales
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

3.  Typologies of Altruistic and Financial Motivations for Research Participation.

Authors:  Lisa J Chin; Jacqueline A Berenson; Robert L Klitzman
Journal:  J Empir Res Hum Res Ethics       Date:  2016-10       Impact factor: 1.742

4.  HIV infection awareness and willingness to participate in future HIV vaccine trials across different risk groups in Abuja, Nigeria.

Authors:  Gambo Aliyu; Mukhtar Mohammad; Ahmed Saidu; Prosanta Mondal; Man Charurat; Alash'le Abimiku; Abdulsalami Nasidi; William Blattner
Journal:  AIDS Care       Date:  2010-10

5.  Characteristics of female sex workers in southern India willing and unwilling to participate in a placebo gel trial.

Authors:  Barbara S Mensch; Barbara A Friedland; Sharon A Abbott; Lauren L Katzen; Waimar Tun; Christine A Kelly; Avina Sarna; Aylur K Srikrishnan; Suniti Solomon
Journal:  AIDS Behav       Date:  2013-02

6.  What leads Indians to participate in clinical trials? A meta-analysis of qualitative studies.

Authors:  Jatin Y Shah; Amruta Phadtare; Dimple Rajgor; Meenakshi Vaghasia; Shreyasee Pradhan; Hilary Zelko; Ricardo Pietrobon
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

7.  Cognitive factors and willingness to participate in an HIV vaccine trial among HIV-negative injection drug users.

Authors:  Shayesta Dhalla; Gary Poole; Joel Singer; David M Patrick; Evan Wood; Thomas Kerr
Journal:  Vaccine       Date:  2009-12-29       Impact factor: 3.641

8.  Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.

Authors:  Gershim Asiki; Andrew Abaasa; Eugene Ruzagira; Freddie Kibengo; Ubaldo Bahemuka; Jerry Mulondo; Janet Seeley; Linda-Gail Bekker; Sinead Delany; Pontiano Kaleebu; Anatoli Kamali
Journal:  Vaccine       Date:  2013-09-07       Impact factor: 3.641

9.  Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.

Authors:  Venkatesan Chakrapani; Peter A Newman; Neeti Singhal; Jhalak Jerajani; Murali Shunmugam
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

10.  Acquired immune deficiency syndrome vaccine trials: Managing ethical issues before, during and after the trials.

Authors:  Sanjay Mehendale
Journal:  Perspect Clin Res       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.